Related Experiment Videos
Cell cycle status in human corneal endothelium
1Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. njoyce@vision.eri.harvard.edu
Experimental Eye Research
|August 2, 2005
Summary
As corneal endothelial cells age, they enter a non-replicative state, hindering natural repair mechanisms. This age-related decline in proliferation is linked to specific cell cycle regulators, impacting corneal health and vision.
Area of Science:
- Ophthalmology
- Cell Biology
- Gerontology
Background:
- The corneal endothelium maintains corneal clarity and hydration through barrier and pump functions.
- Loss of endothelial cells leads to corneal edema and vision loss, with limited natural replacement capacity.
- Endothelial cell proliferation is generally absent or very slow, relying on cell migration/enlargement for repair.
Purpose of the Study:
- To investigate the hypothesis that aging corneal endothelial cells enter a replicative senescence-like state.
- To explore the role of age-related changes in cell cycle inhibitors in preventing endothelial cell proliferation.
Main Methods:
- Analysis of human corneal endothelial cells (HCEC) from donors of varying ages.
- Assessment of cellular responses to mitogenic stimulation.
- Evaluation of the expression and activity of cyclin-dependent kinase inhibitors (p27KIP1, p16INK4A, p21CIP1).
Main Results:
- An increasing proportion of aged HCEC exhibit a reduced response to mitogenic stimulation.
- This decreased responsiveness correlates with age-dependent alterations in the expression and activity of p27KIP1, p16INK4A, and p21CIP1.
- These cell cycle inhibitors appear to mediate the age-related refractoriness to proliferation.
Conclusions:
- Aging corneal endothelial cells enter a state resembling replicative senescence, limiting their ability to divide.
- Age-dependent changes in specific cyclin-dependent kinase inhibitors contribute to the loss of proliferative capacity in corneal endothelial cells.
- Understanding these mechanisms is crucial for developing strategies to treat corneal endothelial dysfunction.